日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, and artificial intelligence in advancing quality of care for patients worldwide

平衡全球标准与区域差异,提升乳腺癌诊疗水平:指南、临床研究、精准医疗和人工智能在提升全球患者诊疗质量中的作用

Gnant, Michael

Optimizing axillary lymph node management in early-stage HR+/HER2- breast cancer: Practical strategies for enhanced detection rates

优化早期HR+/HER2-乳腺癌腋窝淋巴结管理:提高检出率的实用策略

Thill, Marc; Cardoso, Maria-João; Criscitiello, Carmen; Kurzeder, Christian; Pruneri, Giancarlo; Riedel, Fabian; García-Sáenz, José Angel; Vidal, Maria; Mattar, André; Srock, Stefanie; Emde, Anna; Coersmeyer, Monique; Gnant, Michael

Federated Deep Learning Enables Cancer Subtyping by Proteomics

联邦深度学习助力蛋白质组学癌症亚型分析

Cai, Zhaoxiang; Boys, Emma L; Noor, Zainab; Aref, Adel T; Xavier, Dylan; Lucas, Natasha; Williams, Steven G; Koh, Jennifer M S; Poulos, Rebecca C; Wu, Yangxiu; Dausmann, Michael; MacKenzie, Karen L; Aguilar-Mahecha, Adriana; Armengol, Carolina; Barranco, Maria M; Basik, Mark; Bowman, Elise D; Clifton-Bligh, Roderick; Connolly, Elizabeth A; Cooper, Wendy A; Dalal, Bhavik; DeFazio, Anna; Filipits, Martin; Flynn, Peter J; Graham, J Dinny; George, Jacob; Gill, Anthony J; Gnant, Michael; Habib, Rosemary; Harris, Curtis C; Harvey, Kate; Horvath, Lisa G; Jackson, Christopher; Kohonen-Corish, Maija R J; Lim, Elgene; Liu, Jia Jenny; Long, Georgina V; Lord, Reginald V; Mann, Graham J; McCaughan, Geoffrey W; Morgan, Lucy; Murphy, Leigh; Nagabushan, Sumanth; Nagrial, Adnan; Navinés, Jordi; Panizza, Benedict J; Samra, Jaswinder S; Scolyer, Richard A; Souglakos, John; Swarbrick, Alexander; Thomas, David; Balleine, Rosemary L; Hains, Peter G; Robinson, Phillip J; Zhong, Qing; Reddel, Roger R

Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial

新辅助阿特珠单抗联合双重 HER2 阻断疗法和表柔比星治疗早期 HER2 阳性乳腺癌女性患者:随机 II 期 ABCSG-52/ATHENE 试验

Rinnerthaler, Gabriel; Egle, Daniel; Bartsch, Rupert; Schmitt, Clemens A; Petzer, Andreas; Balic, Marija; Petru, Edgar; Denison, Ursula; Singer, Christian F; Bjelic-Radisic, Vesna; Gampenrieder, Simon Peter; Knauer, Michael; Sotlar, Karl; Brunner, Christine; Posch, Florian; Hlauschek, Dominik; Sölkner, Lidija; Bago-Horvath, Zsuzsanna; Filipits, Martin; Gili, Manuela; Ritter, Magdalena; Wieser, Verena; Albertini, Carmen; Zaborsky, Nadja; Weiss, Lukas; Marhold, Maximilian; Schneeweiss, Bruno; Pusch, Renate; Gnant, Michael; Greil, Richard

Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2- Early Breast Cancer

CDK4/6抑制剂的疗效和安全性:聚焦HR+/HER2-早期乳腺癌

Klocker, Eva Valentina; Egle, Daniel; Bartsch, Rupert; Rinnerthaler, Gabriel; Gnant, Michael

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

帕博西尼与质子泵抑制剂在早期乳腺癌中的药物相互作用:PALLAS(ABCSG-42/AFT-05/BIG-14-13/PrE0109)探索性分析

Agostinetto, E; Pfeiler, G; Hlauschek, D; Mayer, E L; Lambertini, M; de Azambuja, E; Bellet-Ezquerra, M; Meisel, J L; Rubovszky, G; Zdenkowski, N; Novik, Y; Ruiz-Borrego, M; Gelmon, K A; Mamounas, E P; Iwata, H; Lu, D R; Soelkner, L; Fesl, C; Gnant, M; DeMichele, A

Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)

在早期乳腺癌患者中,帕博西尼联合辅助内分泌治疗的 PALLAS 随机试验中的生活质量和症状严重程度(AFT-05、ABCSG-42、BIG-14-03、PrE0109)

Naughton, M J; Zahrieh, D M; Gnant, M; Zdenkowski, N; Lemieux, J; Mao, J J; Bjelic-Radisic, V; Shinn, E; Balic, M; Thomssen, C; Meisel, J L; Ruiz, G M; Loibl, S; Isaacs, C; Cameron, D; Henao-Carrasco, F M; Goetz, M P; Singer, C F; Werutsky, G; Rugo, H S; Vetter, M; Tseng, L-M; Miller, K; Fitzal, F; Gil Gil, J M; Park, H; Linderholm, B; Bajetta, E; Dayao, Z; Prat, A; Ehrhardt, K; Metzger, O; Arahmani, A; Law, E H; Partridge, A H; Carey, L A; Zoroufy, A; Dueck, A C; O'Brien, P; Hlauschek, D; DeMichele, A; Mayer, E L

The impact of analysis methodology details on invasive breast cancer-free survival in randomized clinical trials

分析方法细节对随机临床试验中侵袭性乳腺癌无进展生存期的影响

Hlauschek, D; Fesl, C; Gnant, M

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

新辅助全身性乳腺癌治疗试验中局部区域治疗报告的核心结果集

Potter, Shelley; Avery, Kerry; Ahmed, Rosina; de Boniface, Jana; Chatterjee, Sanjoy; Dodwell, David; Dubsky, Peter; Federmann, Jingjing; Finestone, Sandra; Gnant, Michael; Hlauschek, Dominik; Iwata, Hiroji; Jiang, Michael Y; Kaidar-Person, Orit; Lee, Han-Byoel; MacKenzie, Mairead; Meyn, Anne; Poortmans, Philip; Poulakaki, Fiorita; Richardson, Andrea L; Sepulveda, Karla A; Spillane, Andrew J; Thompson, Alastair M; Werutsky, Gustavo; Wittmann, Philipp; Wright, Jean L; Zdenkowski, Nicholas; Cowan, Katherine; McIntosh, Stuart A

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis

BRCA1/2 和其他易感基因在接受内分泌治疗(含或不含帕博西尼)的高危激素受体阳性/人表皮生长因子受体 2 阴性乳腺癌患者中的作用:一项 PENELOPE-B 研究的二次分析

Hahnen, Eric; Hauke, Jan; Gelmon, Karen; Marmé, Frederik; Ernst, Corinna; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé; Knudsen, Erik; Im, Seock-Ah; DeMichele, Angela; Van't Veer, Laura; Kim, Sung-Bae; Bear, Harry; McCarthy, Nicole; Rhiem, Kerstin; Turner, Nicholas; Witkiewicz, Agnieszka; Rojo, Federico; Filipits, Martin; Martin, Lesley-Ann; Fasching, Peter A; Schem, Christian; Becker, Kerstin; García-Sáenz, José A; Kelly, Catherine M; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S; Denkert, Carsten; Gnant, Michael; Makris, Andreas; Liu, Yuan; Valota, Olga; Felder, Bärbel; Weber, Karsten; Nekljudova, Valentina; Loibl, Sibylle